Information to investors

Inven2 wants to have a close dialogue with you as an investor and as someone who might have an interest in investing in and contributing to developing our active innovation projects. These are projects that we believe have the potential to become successful businesses

Each year, we evaluate around 100 new inventions. We proceed with around 30% of the proposals as active innovation projects in close cooperation with the inventors. Some inventions are obvious candidates for licencing to established industry, while others have the potential to become companies that develope products and services that can make an impact on the community at large.

Innovation projects that we believe are best developed through business start-ups need competent investors to join, maybe it is you?

 

Exit strategy

Inven2’s goal is to contribute to increased commercialization of inventions. It is crucial to have sufficient capital turnover to assist in the commercialization process in several companies. A stock market listing will be considered a liquidity event for Inven2 and will therefore be used to realize 1/3 of the equity holdings in connection with a listing. As one of the first investors in a company, Inven2 will often need to also realize the remaining 2/3 earlier than many other investors who come in later.

Portfolio businesses

Portfolio businesses

Inven2 has a portfolio comprising 50 companies. We have established them either on our own or alongside investors and others. The point of departure for the companies are research results from innovative researchers. The portfolio value in December 2022 is NOK 11 billion, but this will vary with the value of the individual company and how long we are shareholders in the most valuable companies.
Nykode
Zelluna Immunotherapy logo